Aortic coarctation accounts for 5–8% of congenital heart disease and occurs in up to 6 in every 10,000 live births. While neonatal coarctation is typically treated surgically via thoracotomy and end-to-end anastomosis, endovascular stenting has become the preferred intervention in older children and adults. Despite favourable short-term outcomes, current stent therapies remain associated with long-term risks including persistent hypertension, and this may be linked to mostly off-label use of biliary stents which limit treatment efficacy in paediatric patients. Recent advances in additive manufacturing provide an opportunity to develop bespoke metallic stents tailored to patient-specific anatomy and biomechanics.,Here, we present a preclinical framework for the design, optimisation, fabrication, and evaluation of patient-specific stents for aortic coarctation treatment. Using selective laser melting (SLM) and finite element (FE) modelling, we developed a virtual design platform to generate and optimise Ti6Al4V stent geometries for varying severities of aortic narrowing (10%, 25%, 37.5%, and 50%). The resulting stent designs, with strut width and thickness dimensions ranging from 197.50 × 190.96 µm to 296.50 × 200 µm, were optimised to achieve a target post-expansion lumen diameter of 10 mm while minimising vessel wall stress. Furthermore, modifications to the connector geometry (original to C-connector and S-connector) enhanced stent conformability and reduced vessel wall stress by up to 16.7% and 19%, respectively. Candidate stents were subsequently fabricated by additive manufacturing, post-processed, and mechanically characterised in accordance with relevant regulatory testing standards. Finally, stent deployment was assessed computationally, through benchtop and ex vivo models to evaluate functional performance and deployment feasibility, establishing that optimised Ti6Al4V stents can be used for treatment of aortic coarctations.,Collectively, this work establishes an integrated computational and manufacturing workflow for the development of customised stents for aortic coarctation and demonstrates the potential of additive manufacturing to enable next-generation patient-specific cardiovascular implants.